<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2016-04-13" version="207">
<accession>P02671</accession>
<accession>A8K3E4</accession>
<accession>D3DP14</accession>
<accession>D3DP15</accession>
<accession>Q4QQH7</accession>
<accession>Q9BX62</accession>
<accession>Q9UCH2</accession>
<name>FIBA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Fibrinogen alpha chain</fullName>
</recommendedName>
<component>
<recommendedName>
<fullName>Fibrinopeptide A</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Fibrinogen alpha chain</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">FGA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Biochemistry" volume="31" first="11968" last="11972">
<title>Carboxy-terminal-extended variant of the human fibrinogen alpha subunit: a novel exon conferring marked homology to beta and gamma subunits.</title>
<authorList>
<person name="Fu Y."/>
<person name="Weissbach L."/>
<person name="Plant P.W."/>
<person name="Oddoux C."/>
<person name="Cao Y."/>
<person name="Liang T.J."/>
<person name="Roy S.N."/>
<person name="Redman C.M."/>
<person name="Grieninger G."/>
</authorList>
<dbReference type="PubMed" id="1457396"/>
<dbReference type="DOI" id="10.1021/bi00163a002"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="2">
<citation type="book" date="1994" name="Index of variant human fibrinogens" first="13" last="24" publisher="CRC Press" city="Boca Raton">
<title>Fibrinogen DNA and protein sequences.</title>
<editorList>
<person name="Ebert R.F."/>
</editorList>
<authorList>
<person name="Chung D.W."/>
<person name="Grieninger G."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2001-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS VAL-6; ALA-331 AND ALA-456</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT ALA-331</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1990" name="Adv. Exp. Med. Biol." volume="281" first="39" last="48">
<title>Nucleotide sequences of the three genes coding for human fibrinogen.</title>
<authorList>
<person name="Chung D.W."/>
<person name="Harris J.E."/>
<person name="Davie E.W."/>
</authorList>
<dbReference type="PubMed" id="2102623"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE OF 1-655 (ISOFORM 1)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1983" name="Proc. Natl. Acad. Sci. U.S.A." volume="80" first="3953" last="3957">
<title>Partial mRNA sequences for human A alpha, B beta, and gamma fibrinogen chains: evolutionary and functional implications.</title>
<authorList>
<person name="Kant J.A."/>
<person name="Lord S.T."/>
<person name="Crabtree G.R."/>
</authorList>
<dbReference type="PubMed" id="6575389"/>
<dbReference type="DOI" id="10.1073/pnas.80.13.3953"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1983" name="Biochemistry" volume="22" first="3237" last="3244">
<title>Characterization of a complementary deoxyribonucleic acid coding for the alpha chain of human fibrinogen.</title>
<authorList>
<person name="Rixon M.W."/>
<person name="Chan W.-Y."/>
<person name="Davie E.W."/>
<person name="Chung D.W."/>
</authorList>
<dbReference type="PubMed" id="6688355"/>
<dbReference type="DOI" id="10.1021/bi00282a031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-629</scope>
</reference>
<reference key="10">
<citation type="book" date="1980" name="Protides of the biological fluids, Proc. 28th colloquium" first="51" last="56" publisher="Pergamon Press" city="Oxford">
<title>Human fibrinogen: sequence, sulfur bridges, glycosylation and some structural variants.</title>
<editorList>
<person name="Peeters H."/>
</editorList>
<authorList>
<person name="Henschen A."/>
<person name="Lottspeich F."/>
<person name="Southan C."/>
<person name="Topfer-Petersen E."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 20-629</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1979" name="Biochemistry" volume="18" first="5410" last="5416">
<title>Amino acid sequence studies on the alpha chain of human fibrinogen. Overlapping sequences providing the complete sequence.</title>
<authorList>
<person name="Watt K.W.K."/>
<person name="Cottrell B.A."/>
<person name="Strong D.D."/>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="518846"/>
<dbReference type="DOI" id="10.1021/bi00591a024"/>
</citation>
<scope>PROTEIN SEQUENCE OF 20-629</scope>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1983" name="Nucleic Acids Res." volume="11" first="7427" last="7434">
<title>Isolation and characterisation of cDNA clones for the A alpha- and gamma-chains of human fibrinogen.</title>
<authorList>
<person name="Imam A.M.A."/>
<person name="Eaton M.A.W."/>
<person name="Williamson R."/>
<person name="Humphries S."/>
</authorList>
<dbReference type="PubMed" id="6689067"/>
<dbReference type="DOI" id="10.1093/nar/11.21.7427"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 110-156</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1983" name="Ann. N. Y. Acad. Sci." volume="408" first="449" last="456">
<title>Cloning of fibrinogen genes and their cDNA.</title>
<authorList>
<person name="Chung D.W."/>
<person name="Rixon M.W."/>
<person name="Que B.G."/>
<person name="Davie E.W."/>
</authorList>
<dbReference type="PubMed" id="6575700"/>
<dbReference type="DOI" id="10.1111/j.1749-6632.1983.tb23265.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE OF 605-644 (ISOFORM 2)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1965" name="Acta Chem. Scand." volume="19" first="1788" last="1789">
<title>Studies on fibrinopeptides from primates.</title>
<authorList>
<person name="Blombaeck B."/>
<person name="Blombaeck M."/>
<person name="Grondahl N.J."/>
<person name="Guthrie C."/>
<person name="Hinton M."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 20-35</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1978" name="Thromb. Res." volume="13" first="557" last="562">
<title>The arrangement of disulfide bonds in fragment D from human fibrinogen.</title>
<authorList>
<person name="Bouma H."/>
<person name="Takagi T."/>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="741445"/>
<dbReference type="DOI" id="10.1016/0049-3848(78)90142-1"/>
</citation>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1979" name="Biochemistry" volume="18" first="5405" last="5410">
<title>Amino acid sequence studies on the alpha chain of human fibrinogen. Exact location of cross-linking acceptor sites.</title>
<authorList>
<person name="Cottrell B.A."/>
<person name="Strong D.D."/>
<person name="Watt K.W.K."/>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="518845"/>
<dbReference type="DOI" id="10.1021/bi00591a023"/>
</citation>
<scope>CROSS-LINKING ACCEPTOR SITES</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1978" name="J. Biol. Chem." volume="253" first="2184" last="2195">
<title>Localization of the alpha-chain cross-link acceptor sites of human fibrin.</title>
<authorList>
<person name="Fretto L.J."/>
<person name="Ferguson E.W."/>
<person name="Steinman H.M."/>
<person name="McKee P.A."/>
</authorList>
<dbReference type="PubMed" id="632262"/>
</citation>
<scope>CROSS-LINKING ACCEPTOR SITES</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-686</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="1976" name="Thromb. Res." volume="8" first="639" last="658">
<title>Disulfide bridges in NH2-terminal part of human fibrinogen.</title>
<authorList>
<person name="Blombaeck B."/>
<person name="Hessel B."/>
<person name="Hogg D."/>
</authorList>
<dbReference type="PubMed" id="936108"/>
<dbReference type="DOI" id="10.1016/0049-3848(76)90245-0"/>
</citation>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1984" name="Annu. Rev. Biochem." volume="53" first="195" last="229">
<title>Fibrinogen and fibrin.</title>
<authorList>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="6383194"/>
</citation>
<scope>REVIEW</scope>
<scope>ELECTRON MICROSCOPY</scope>
<scope>POLYMERIZATION</scope>
<scope>LIGANDS</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1986" name="J. Biol. Chem." volume="261" first="15591" last="15595">
<title>Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.</title>
<authorList>
<person name="Kimura S."/>
<person name="Aoki N."/>
</authorList>
<dbReference type="PubMed" id="2877981"/>
</citation>
<scope>CROSS-LINKING SITE FOR ALPHA-2-PLASMIN INHIBITOR</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1983" name="Biochem. Biophys. Res. Commun." volume="117" first="631" last="636">
<title>Phosphorylation of fibrinogen by casein kinase 1.</title>
<authorList>
<person name="Itarte E."/>
<person name="Plana M."/>
<person name="Guasch M.D."/>
<person name="Martos C."/>
</authorList>
<dbReference type="PubMed" id="6318767"/>
<dbReference type="DOI" id="10.1016/0006-291X(83)91247-0"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="Pituitary" volume="9" first="109" last="120">
<title>Phosphoproteomic analysis of the human pituitary.</title>
<authorList>
<person name="Beranova-Giorgianni S."/>
<person name="Zhao Y."/>
<person name="Desiderio D.M."/>
<person name="Giorgianni F."/>
</authorList>
<dbReference type="PubMed" id="16807684"/>
<dbReference type="DOI" id="10.1007/s11102-006-8916-x"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Pituitary</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-412 AND SER-609</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="29041" last="29049">
<title>Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics.</title>
<authorList>
<person name="Ono M."/>
<person name="Matsubara J."/>
<person name="Honda K."/>
<person name="Sakuma T."/>
<person name="Hashiguchi T."/>
<person name="Nose H."/>
<person name="Nakamori S."/>
<person name="Okusaka T."/>
<person name="Kosuge T."/>
<person name="Sata N."/>
<person name="Nagai H."/>
<person name="Ioka T."/>
<person name="Tanaka S."/>
<person name="Tsuchida A."/>
<person name="Aoki T."/>
<person name="Shimahara M."/>
<person name="Yasunami Y."/>
<person name="Itoi T."/>
<person name="Moriyasu F."/>
<person name="Negishi A."/>
<person name="Kuwabara H."/>
<person name="Shoji A."/>
<person name="Hirohashi S."/>
<person name="Yamada T."/>
</authorList>
<dbReference type="PubMed" id="19696023"/>
<dbReference type="DOI" id="10.1074/jbc.M109.041749"/>
</citation>
<scope>HYDROXYLATION AT PRO-565</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-686</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="13669" last="13676">
<title>A unique proteolytic fragment of human fibrinogen containing the A alpha COOH-terminal domain of the native molecule.</title>
<authorList>
<person name="Kirschbaum N.E."/>
<person name="Budzynski A.Z."/>
</authorList>
<dbReference type="PubMed" id="2143188"/>
</citation>
<scope>CLEAVAGE BY HEMENTIN AND PLASMIN</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="J. Proteome Res." volume="11" first="5804" last="5814">
<title>Glycoproteomic analysis of human fibrinogen reveals novel regions of O-glycosylation.</title>
<authorList>
<person name="Zauner G."/>
<person name="Hoffmann M."/>
<person name="Rapp E."/>
<person name="Koeleman C.A."/>
<person name="Dragan I."/>
<person name="Deelder A.M."/>
<person name="Wuhrer M."/>
<person name="Hensbergen P.J."/>
</authorList>
<dbReference type="PubMed" id="23050552"/>
<dbReference type="DOI" id="10.1021/pr3005937"/>
</citation>
<scope>GLYCOSYLATION AT THR-320 AND SER-351</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="444" last="454">
<title>Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis.</title>
<authorList>
<person name="Adamczyk B."/>
<person name="Struwe W.B."/>
<person name="Ercan A."/>
<person name="Nigrovic P.A."/>
<person name="Rudd P.M."/>
</authorList>
<dbReference type="PubMed" id="23151259"/>
<dbReference type="DOI" id="10.1021/pr300813h"/>
</citation>
<scope>LACK OF GLYCOSYLATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-50; SER-281; SER-291; SER-294; THR-412; SER-451; SER-501; THR-505 AND SER-609</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2015" name="Cell" volume="161" first="1619" last="1632">
<title>A single kinase generates the majority of the secreted phosphoproteome.</title>
<authorList>
<person name="Tagliabracci V.S."/>
<person name="Wiley S.E."/>
<person name="Guo X."/>
<person name="Kinch L.N."/>
<person name="Durrant E."/>
<person name="Wen J."/>
<person name="Xiao J."/>
<person name="Cui J."/>
<person name="Nguyen K.B."/>
<person name="Engel J.L."/>
<person name="Coon J.J."/>
<person name="Grishin N."/>
<person name="Pinna L.A."/>
<person name="Pagliarini D.J."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="26091039"/>
<dbReference type="DOI" id="10.1016/j.cell.2015.05.028"/>
</citation>
<scope>PHOSPHORYLATION AT SER-45; SER-56; SER-364; SER-524; SER-560 AND SER-609</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="7911" last="7920">
<title>The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution.</title>
<authorList>
<person name="Martin P.D."/>
<person name="Robertson W."/>
<person name="Turk D."/>
<person name="Huber R."/>
<person name="Bode W."/>
<person name="Edwards B.F.P."/>
</authorList>
<dbReference type="PubMed" id="1560020"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 26-39</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1997" name="Nature" volume="389" first="455" last="462">
<title>Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.</title>
<authorList>
<person name="Spraggon G."/>
<person name="Everse S.J."/>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="9333233"/>
<dbReference type="DOI" id="10.1038/38947"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 130-216</scope>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="8637" last="8642">
<title>Crystal structure of fragment double-D from human fibrin with two different bound ligands.</title>
<authorList>
<person name="Everse S.J."/>
<person name="Spraggon G."/>
<person name="Veerapandian L."/>
<person name="Riley M."/>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="9628725"/>
<dbReference type="DOI" id="10.1021/bi9804129"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 130-216</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>COILED COIL DOMAIN</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="9099" last="9104">
<title>Crystal structure of a recombinant alphaEC domain from human fibrinogen-420.</title>
<authorList>
<person name="Spraggon G."/>
<person name="Applegate D."/>
<person name="Everse S.J."/>
<person name="Zhang J.Z."/>
<person name="Veerapandian L."/>
<person name="Redman C."/>
<person name="Doolittle R.F."/>
<person name="Grieninger G."/>
</authorList>
<dbReference type="PubMed" id="9689040"/>
<dbReference type="DOI" id="10.1073/pnas.95.16.9099"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 666-866 IN COMPLEX WITH CALCIUM IONS</scope>
<scope>GLYCOSYLATION AT ASN-686</scope>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1999" name="Biochemistry" volume="38" first="2941" last="2946">
<title>Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide.</title>
<authorList>
<person name="Everse S.J."/>
<person name="Spraggon G."/>
<person name="Veerapandian L."/>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="10074346"/>
<dbReference type="DOI" id="10.1021/bi982626w"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 130-216</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="3877" last="3886">
<title>Crystal structure of human fibrinogen.</title>
<authorList>
<person name="Kollman J.M."/>
<person name="Pandi L."/>
<person name="Sawaya M.R."/>
<person name="Riley M."/>
<person name="Doolittle R.F."/>
</authorList>
<dbReference type="PubMed" id="19296670"/>
<dbReference type="DOI" id="10.1021/bi802205g"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 20-581</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>COILED COIL DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1991" name="Blood" volume="78" first="149" last="153">
<title>Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of A alpha proline-18 by leucine.</title>
<authorList>
<person name="Yoshida N."/>
<person name="Okuma M."/>
<person name="Hirata H."/>
<person name="Matsuda M."/>
<person name="Yamazumi K."/>
<person name="Asakura S."/>
</authorList>
<dbReference type="PubMed" id="2070049"/>
</citation>
<scope>VARIANT KYOTO-2 LEU-37</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1992" name="J. Clin. Invest." volume="90" first="67" last="76">
<title>Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator.</title>
<authorList>
<person name="Maekawa H."/>
<person name="Yamazumi K."/>
<person name="Muramatsu S."/>
<person name="Kaneko M."/>
<person name="Hirata H."/>
<person name="Takahashi N."/>
<person name="Arocha-Pinango C.L."/>
<person name="Rodriguez S."/>
<person name="Nagy H."/>
<person name="Perez-Requejo J.L."/>
<person name="Matsuda M."/>
</authorList>
<dbReference type="PubMed" id="1634621"/>
<dbReference type="DOI" id="10.1172/JCI115857"/>
</citation>
<scope>VARIANT LIMA SER-160</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="11575" last="11581">
<title>An A alpha Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation.</title>
<authorList>
<person name="Maekawa H."/>
<person name="Yamazumi K."/>
<person name="Muramatsu S."/>
<person name="Kaneko M."/>
<person name="Hirata H."/>
<person name="Takahashi N."/>
<person name="de Bosch N.B."/>
<person name="Carvajal Z."/>
<person name="Ojeda A."/>
<person name="Arocha-Pinango C.L."/>
<person name="Matsuda M."/>
</authorList>
<dbReference type="PubMed" id="1675636"/>
</citation>
<scope>VARIANT CARACAS-2 ASN-453</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1993" name="J. Clin. Invest." volume="91" first="1637" last="1643">
<title>Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.</title>
<authorList>
<person name="Koopman J."/>
<person name="Haverkate F."/>
<person name="Grimbergen J."/>
<person name="Lord S.T."/>
<person name="Mosesson M.W."/>
<person name="Diorio J.P."/>
<person name="Siebenlist K.S."/>
<person name="Legrand C."/>
<person name="Soria J."/>
<person name="Soria C."/>
<person name="Caen J.P."/>
</authorList>
<dbReference type="PubMed" id="8473507"/>
<dbReference type="DOI" id="10.1172/JCI116371"/>
</citation>
<scope>INVOLVEMENT IN DYSFIBRIN</scope>
<scope>VARIANT DYSFIBRIN CYS-573</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1993" name="Nat. Genet." volume="3" first="252" last="255">
<title>Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain.</title>
<authorList>
<person name="Benson M.D."/>
<person name="Liepnieks J."/>
<person name="Uemichi T."/>
<person name="Wheeler G."/>
<person name="Correa R."/>
</authorList>
<dbReference type="PubMed" id="8097946"/>
<dbReference type="DOI" id="10.1038/ng0393-252"/>
</citation>
<scope>VARIANT AMYL8 LEU-573</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1993" name="Surg. Today" volume="23" first="45" last="50">
<title>Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.</title>
<authorList>
<person name="Yamazumi K."/>
<person name="Terukina S."/>
<person name="Matsuda M."/>
<person name="Kanbayashi J."/>
<person name="Sakon M."/>
<person name="Tsujinaka T."/>
</authorList>
<dbReference type="PubMed" id="8461606"/>
<dbReference type="DOI" id="10.1007/BF00308999"/>
</citation>
<scope>VARIANT OSAKA IV HIS-35</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1995" name="J. Clin. Invest." volume="96" first="2854" last="2858">
<title>Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A-alpha 20 Val-to-Asp).</title>
<authorList>
<person name="Brennan S.O."/>
<person name="Hammonds B."/>
<person name="George P.M."/>
</authorList>
<dbReference type="PubMed" id="8675656"/>
<dbReference type="DOI" id="10.1172/JCI118356"/>
</citation>
<scope>VARIANT CANTERBURY ASP-39</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="231" last="238">
<title>Characterization of single-nucleotide polymorphisms in coding regions of human genes.</title>
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="10391209"/>
<dbReference type="DOI" id="10.1038/10290"/>
</citation>
<scope>VARIANTS ALA-331 AND GLU-446</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="373" last="373">
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2006" name="Br. J. Haematol." volume="134" first="220" last="226">
<title>The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance.</title>
<authorList>
<person name="Flood V.H."/>
<person name="Al-Mondhiry H.A."/>
<person name="Farrell D.H."/>
</authorList>
<dbReference type="PubMed" id="16846481"/>
<dbReference type="DOI" id="10.1111/j.1365-2141.2006.06129.x"/>
</citation>
<scope>INVOLVEMENT IN DYSFIBRIN</scope>
<scope>VARIANT DYSFIBRIN CYS-35</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2015" name="Thromb. Haemost." volume="113" first="567" last="576">
<title>Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.</title>
<authorList>
<person name="Asselta R."/>
<person name="Plate M."/>
<person name="Robusto M."/>
<person name="Borhany M."/>
<person name="Guella I."/>
<person name="Solda G."/>
<person name="Afrasiabi A."/>
<person name="Menegatti M."/>
<person name="Shamsi T."/>
<person name="Peyvandi F."/>
<person name="Duga S."/>
</authorList>
<dbReference type="PubMed" id="25427968"/>
<dbReference type="DOI" id="10.1160/TH14-07-0629"/>
</citation>
<scope>INVOLVEMENT IN CAFBN; VARIANTS CAFBN ARG-55; PRO-129 AND TRP-184</scope>
<scope>CHARACTERIZATION OF VARIANTS CAFBN ARG-55; PRO-129 AND TRP-184</scope>
</reference>
<comment type="function">
<text evidence="12">Cleaved by the protease thrombin to yield monomers which, together with fibrinogen beta (FGB) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However, subsequent studies have shown that it is not absolutely required for thrombus formation in vivo. Enhances expression of SELP in activated platelets via an ITGB3-dependent pathway. Maternal fibrinogen is essential for successful pregnancy. Fibrin deposition is also associated with infection, where it protects against IFNG-mediated hemorrhage. May also facilitate the immune response via both innate and T-cell mediated pathways.</text>
</comment>
<comment type="subunit">
<text evidence="31 32 37 38 39 40">Heterohexamer; disulfide linked. Contains 2 sets of 3 non-identical chains (alpha, beta and gamma). The 2 heterotrimers are in head to head conformation with the N-termini in a small central domain.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-348571"/>
<interactant intactId="EBI-701692">
<id>P02647</id>
<label>APOA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="23 39">Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P02671-1</id>
<name>1</name>
<name>Alpha-E</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P02671-2</id>
<name>2</name>
<name>Alpha</name>
<sequence type="described" ref="VSP_001531 VSP_001532"/>
<text evidence="47">Ref.3 (AAK31372) sequence is in conflict in positions: 640:PSLSP->LPCPPRLS.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="23 39">Detected in blood plasma (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="23 39 47">A long coiled coil structure formed by 3 polypeptide chains connects the central nodule to the C-terminal domains (distal nodules). The long C-terminal ends of the alpha chains fold back, contributing a fourth strand to the coiled coil structure.</text>
</comment>
<comment type="PTM">
<text evidence="18 22 28 40 47">The alpha chain is normally not N-glycosylated (PubMed:23151259), even though glycosylation at Asn-686 was observed when a fragment of the protein was expressed in insect cells (PubMed:9689040). It is well known that heterologous expression of isolated domains can lead to adventitious protein modifications. Besides, glycosylation at Asn-686 is supported by large-scale glycoproteomics studies (PubMed:16335952 and PubMed:19159218), but the evidence is still quite tenuous. Most likely, Asn-686 is not glycosylated in the healthy human body, or only with low efficiency.</text>
</comment>
<comment type="PTM">
<text evidence="27">O-glycosylated.</text>
</comment>
<comment type="PTM">
<text>Forms F13A-mediated cross-links between a glutamine and the epsilon-amino group of a lysine residue, forming fibronectin-fibrinogen heteropolymers.</text>
</comment>
<comment type="PTM">
<text>About one-third of the alpha chains in the molecules in blood were found to be phosphorylated.</text>
</comment>
<comment type="PTM">
<text evidence="26">Conversion of fibrinogen to fibrin is triggered by thrombin, which cleaves fibrinopeptides A and B from alpha and beta chains, and thus exposes the N-terminal polymerization sites responsible for the formation of the soft clot. The soft clot is converted into the hard clot by factor XIIIA which catalyzes the epsilon-(gamma-glutamyl)lysine cross-linking between gamma chains (stronger) and between alpha chains (weaker) of different monomers.</text>
</comment>
<comment type="PTM">
<text evidence="30">Phosphorylated by FAM20C in the extracellular medium.</text>
</comment>
<comment type="disease" evidence="29">
<disease id="DI-01387">
<name>Congenital afibrinogenemia</name>
<acronym>CAFBN</acronym>
<description>Rare autosomal recessive disorder is characterized by bleeding that varies from mild to severe and by complete absence or extremely low levels of plasma and platelet fibrinogen.</description>
<dbReference type="MIM" id="202400"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry. The majority of cases of afibrinogenemia are due to truncating mutations. Variations in position Arg-35 (the site of cleavage of fibrinopeptide a by thrombin) leads to alpha-dysfibrinogenemias.</text>
</comment>
<comment type="disease" evidence="33">
<disease id="DI-00104">
<name>Amyloidosis 8</name>
<acronym>AMYL8</acronym>
<description>A hereditary generalized amyloidosis due to deposition of apolipoprotein A1, fibrinogen and lysozyme amyloids. Viscera are particularly affected. There is no involvement of the nervous system. Clinical features include renal amyloidosis resulting in nephrotic syndrome, arterial hypertension, hepatosplenomegaly, cholestasis, petechial skin rash.</description>
<dbReference type="MIM" id="105200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21 35">
<disease id="DI-04218">
<name>Dysfibrinogenemia, congenital</name>
<acronym>DYSFIBRIN</acronym>
<description>A disorder characterized by qualitative abnormalities (dysfibrinogenemia) of the circulating fibrinogen. Affected individuals are frequently asymptomatic, but some patients have bleeding diathesis, thromboembolic complications, or both. In some cases, dysfibrinogenemia is associated with low circulating fibrinogen levels (hypodysfibrinogenemia).</description>
<dbReference type="MIM" id="616004"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="15">Contains 1 fibrinogen C-terminal domain.</text>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=FGA"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Fibrinogen"/>
<text>Fibrinogen entry</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/fga/"/>
</comment>
<dbReference type="EMBL" id="M64982">
<property type="protein sequence ID" value="AAA17056.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M64982">
<property type="protein sequence ID" value="AAA17055.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M58569">
<property type="protein sequence ID" value="AAC97142.1"/>
<property type="molecule type" value="Transcribed_RNA"/>
</dbReference>
<dbReference type="EMBL" id="M58569">
<property type="protein sequence ID" value="AAC97143.1"/>
<property type="molecule type" value="Transcribed_RNA"/>
</dbReference>
<dbReference type="EMBL" id="AF361104">
<property type="protein sequence ID" value="AAK31372.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF361104">
<property type="protein sequence ID" value="AAK31373.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290559">
<property type="protein sequence ID" value="BAF83248.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471056">
<property type="protein sequence ID" value="EAX04925.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471056">
<property type="protein sequence ID" value="EAX04926.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471056">
<property type="protein sequence ID" value="EAX04927.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471056">
<property type="protein sequence ID" value="EAX04928.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098280">
<property type="protein sequence ID" value="AAH98280.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC099706">
<property type="protein sequence ID" value="AAH99706.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC099720">
<property type="protein sequence ID" value="AAH99720.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC101935">
<property type="protein sequence ID" value="AAI01936.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J00128">
<property type="protein sequence ID" value="AAA52427.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J00127">
<property type="protein sequence ID" value="AAA52426.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K02272">
<property type="protein sequence ID" value="AAA52428.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M26878">
<property type="protein sequence ID" value="AAA52444.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3787.1">
<molecule id="P02671-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47152.1">
<molecule id="P02671-2"/>
</dbReference>
<dbReference type="PIR" id="A93956">
<property type="entry name" value="FGHUA"/>
</dbReference>
<dbReference type="PIR" id="D44234">
<property type="entry name" value="D44234"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000499.1">
<molecule id="P02671-1"/>
<property type="nucleotide sequence ID" value="NM_000508.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_068657.1">
<molecule id="P02671-2"/>
<property type="nucleotide sequence ID" value="NM_021871.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.351593"/>
<dbReference type="UniGene" id="Hs.612036"/>
<dbReference type="PDB" id="1BBR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="F/G/I=26-35"/>
</dbReference>
<dbReference type="PDB" id="1DM4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C=26-35"/>
</dbReference>
<dbReference type="PDB" id="1FPH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="F=26-35"/>
</dbReference>
<dbReference type="PDB" id="1FZA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="1FZB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="1FZC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="1FZD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B/C/D/E/F/G/H=666-866"/>
</dbReference>
<dbReference type="PDB" id="1FZE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="1FZF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="1FZG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="1LT9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="1LTJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="1N86">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="1N8E">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="A/D=130-218"/>
</dbReference>
<dbReference type="PDB" id="1RE3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="1RE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="1RF0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="1RF1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.53"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="1YCP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="F/N=20-42"/>
</dbReference>
<dbReference type="PDB" id="2A45">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.65"/>
<property type="chains" value="G/J=36-92"/>
</dbReference>
<dbReference type="PDB" id="2FFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="2H43">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="2HLO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="2HOD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/D/G/J=130-216"/>
</dbReference>
<dbReference type="PDB" id="2HPC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/D/G/J=130-216"/>
</dbReference>
<dbReference type="PDB" id="2OYH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="2OYI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="2Q9I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="2XNX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/D/G/J=130-216"/>
</dbReference>
<dbReference type="PDB" id="2XNY">
<property type="method" value="X-ray"/>
<property type="resolution" value="7.50"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="2Z4E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="3AT0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=332-347"/>
</dbReference>
<dbReference type="PDB" id="3BVH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/D=148-209"/>
</dbReference>
<dbReference type="PDB" id="3E1I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/D=130-216"/>
</dbReference>
<dbReference type="PDB" id="3GHG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/D/G/J=20-581"/>
</dbReference>
<dbReference type="PDB" id="3H32">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/D=20-216"/>
</dbReference>
<dbReference type="PDB" id="3HUS">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.04"/>
<property type="chains" value="A/D=145-210"/>
</dbReference>
<dbReference type="PDB" id="4F27">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="Q=336-347"/>
</dbReference>
<dbReference type="PDB" id="5CFA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="C/D=580-594"/>
</dbReference>
<dbReference type="PDBsum" id="1BBR"/>
<dbReference type="PDBsum" id="1DM4"/>
<dbReference type="PDBsum" id="1FPH"/>
<dbReference type="PDBsum" id="1FZA"/>
<dbReference type="PDBsum" id="1FZB"/>
<dbReference type="PDBsum" id="1FZC"/>
<dbReference type="PDBsum" id="1FZD"/>
<dbReference type="PDBsum" id="1FZE"/>
<dbReference type="PDBsum" id="1FZF"/>
<dbReference type="PDBsum" id="1FZG"/>
<dbReference type="PDBsum" id="1LT9"/>
<dbReference type="PDBsum" id="1LTJ"/>
<dbReference type="PDBsum" id="1N86"/>
<dbReference type="PDBsum" id="1N8E"/>
<dbReference type="PDBsum" id="1RE3"/>
<dbReference type="PDBsum" id="1RE4"/>
<dbReference type="PDBsum" id="1RF0"/>
<dbReference type="PDBsum" id="1RF1"/>
<dbReference type="PDBsum" id="1YCP"/>
<dbReference type="PDBsum" id="2A45"/>
<dbReference type="PDBsum" id="2FFD"/>
<dbReference type="PDBsum" id="2H43"/>
<dbReference type="PDBsum" id="2HLO"/>
<dbReference type="PDBsum" id="2HOD"/>
<dbReference type="PDBsum" id="2HPC"/>
<dbReference type="PDBsum" id="2OYH"/>
<dbReference type="PDBsum" id="2OYI"/>
<dbReference type="PDBsum" id="2Q9I"/>
<dbReference type="PDBsum" id="2XNX"/>
<dbReference type="PDBsum" id="2XNY"/>
<dbReference type="PDBsum" id="2Z4E"/>
<dbReference type="PDBsum" id="3AT0"/>
<dbReference type="PDBsum" id="3BVH"/>
<dbReference type="PDBsum" id="3E1I"/>
<dbReference type="PDBsum" id="3GHG"/>
<dbReference type="PDBsum" id="3H32"/>
<dbReference type="PDBsum" id="3HUS"/>
<dbReference type="PDBsum" id="4F27"/>
<dbReference type="PDBsum" id="5CFA"/>
<dbReference type="ProteinModelPortal" id="P02671"/>
<dbReference type="SMR" id="P02671">
<property type="residue range" value="46-231, 411-524, 596-866"/>
</dbReference>
<dbReference type="BioGrid" id="108534">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="DIP" id="DIP-29643N"/>
<dbReference type="IntAct" id="P02671">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="MINT-1033042"/>
<dbReference type="STRING" id="9606.ENSP00000306361"/>
<dbReference type="ChEMBL" id="CHEMBL2364709"/>
<dbReference type="DrugBank" id="DB00009">
<property type="generic name" value="Alteplase"/>
</dbReference>
<dbReference type="DrugBank" id="DB00029">
<property type="generic name" value="Anistreplase"/>
</dbReference>
<dbReference type="DrugBank" id="DB00015">
<property type="generic name" value="Reteplase"/>
</dbReference>
<dbReference type="DrugBank" id="DB00364">
<property type="generic name" value="Sucralfate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00031">
<property type="generic name" value="Tenecteplase"/>
</dbReference>
<dbReference type="iPTMnet" id="P02671"/>
<dbReference type="PhosphoSite" id="P02671"/>
<dbReference type="SwissPalm" id="P02671"/>
<dbReference type="UniCarbKB" id="P02671"/>
<dbReference type="BioMuta" id="FGA"/>
<dbReference type="DMDM" id="1706799"/>
<dbReference type="OGP" id="P02671"/>
<dbReference type="SWISS-2DPAGE" id="P02671"/>
<dbReference type="MaxQB" id="P02671"/>
<dbReference type="PaxDb" id="P02671"/>
<dbReference type="PeptideAtlas" id="P02671"/>
<dbReference type="PRIDE" id="P02671"/>
<dbReference type="DNASU" id="2243"/>
<dbReference type="Ensembl" id="ENST00000302053">
<molecule id="P02671-1"/>
<property type="protein sequence ID" value="ENSP00000306361"/>
<property type="gene ID" value="ENSG00000171560"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000403106">
<molecule id="P02671-2"/>
<property type="protein sequence ID" value="ENSP00000385981"/>
<property type="gene ID" value="ENSG00000171560"/>
</dbReference>
<dbReference type="GeneID" id="2243"/>
<dbReference type="KEGG" id="hsa:2243"/>
<dbReference type="UCSC" id="uc003iod.2">
<molecule id="P02671-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2243"/>
<dbReference type="GeneCards" id="FGA"/>
<dbReference type="HGNC" id="HGNC:3661">
<property type="gene designation" value="FGA"/>
</dbReference>
<dbReference type="HPA" id="CAB016776"/>
<dbReference type="HPA" id="HPA051370"/>
<dbReference type="MalaCards" id="FGA"/>
<dbReference type="MIM" id="105200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="134820">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="202400">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616004">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P02671"/>
<dbReference type="Orphanet" id="98880">
<property type="disease" value="Familial afibrinogenemia"/>
</dbReference>
<dbReference type="Orphanet" id="98881">
<property type="disease" value="Familial dysfibrinogenemia"/>
</dbReference>
<dbReference type="Orphanet" id="248408">
<property type="disease" value="Familial hypodysfibrinogenemia"/>
</dbReference>
<dbReference type="Orphanet" id="101041">
<property type="disease" value="Familial hypofibrinogenemia"/>
</dbReference>
<dbReference type="Orphanet" id="93562">
<property type="disease" value="Familial renal amyloidosis due to fibrinogen A alpha-chain variant"/>
</dbReference>
<dbReference type="PharmGKB" id="PA429"/>
<dbReference type="eggNOG" id="KOG2579">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZYS4">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00830000128240"/>
<dbReference type="HOGENOM" id="HOG000285947"/>
<dbReference type="HOVERGEN" id="HBG005668"/>
<dbReference type="InParanoid" id="P02671"/>
<dbReference type="KO" id="K03903"/>
<dbReference type="OMA" id="PGSTGTW"/>
<dbReference type="OrthoDB" id="EOG7X9G60"/>
<dbReference type="PhylomeDB" id="P02671"/>
<dbReference type="TreeFam" id="TF351984"/>
<dbReference type="Reactome" id="R-HSA-114608">
<property type="pathway name" value="Platelet degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-140875">
<property type="pathway name" value="Common Pathway of Fibrin Clot Formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-216083">
<property type="pathway name" value="Integrin cell surface interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-354192">
<property type="pathway name" value="Integrin alphaIIb beta3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-354194">
<property type="pathway name" value="GRB2:SOS provides linkage to MAPK signaling for Integrins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-372708">
<property type="pathway name" value="p130Cas linkage to MAPK signaling for integrins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977225">
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="ChiTaRS" id="FGA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P02671"/>
<dbReference type="GeneWiki" id="Fibrinogen_alpha_chain"/>
<dbReference type="GenomeRNAi" id="2243"/>
<dbReference type="NextBio" id="35464018"/>
<dbReference type="PMAP-CutDB" id="P02671"/>
<dbReference type="PRO" id="PR:P02671"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="Bgee" id="P02671"/>
<dbReference type="CleanEx" id="HS_FGA"/>
<dbReference type="ExpressionAtlas" id="P02671">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P02671">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0072562">
<property type="term" value="C:blood microparticle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903561">
<property type="term" value="C:extracellular vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005577">
<property type="term" value="C:fibrinogen complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031091">
<property type="term" value="C:platelet alpha granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031093">
<property type="term" value="C:platelet alpha granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005791">
<property type="term" value="C:rough endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005198">
<property type="term" value="F:structural molecule activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006953">
<property type="term" value="P:acute-phase response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002250">
<property type="term" value="P:adaptive immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0072377">
<property type="term" value="P:blood coagulation, common pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0072378">
<property type="term" value="P:blood coagulation, fibrin clot formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007160">
<property type="term" value="P:cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043623">
<property type="term" value="P:cellular protein complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1990643">
<property type="term" value="P:cellular response to granulocyte colony-stimulating factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071354">
<property type="term" value="P:cellular response to interleukin-6"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071407">
<property type="term" value="P:cellular response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042730">
<property type="term" value="P:fibrinolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043152">
<property type="term" value="P:induction of bacterial agglutination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0097421">
<property type="term" value="P:liver regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000261">
<property type="term" value="P:negative regulation of blood coagulation, common pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000352">
<property type="term" value="P:negative regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031639">
<property type="term" value="P:plasminogen activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070527">
<property type="term" value="P:platelet aggregation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002576">
<property type="term" value="P:platelet degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045921">
<property type="term" value="P:positive regulation of exocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034116">
<property type="term" value="P:positive regulation of heterotypic cell-cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090277">
<property type="term" value="P:positive regulation of peptide hormone secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050714">
<property type="term" value="P:positive regulation of protein secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900026">
<property type="term" value="P:positive regulation of substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045907">
<property type="term" value="P:positive regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006461">
<property type="term" value="P:protein complex assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051258">
<property type="term" value="P:protein polymerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051592">
<property type="term" value="P:response to calcium ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046898">
<property type="term" value="P:response to cycloheximide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033595">
<property type="term" value="P:response to genistein"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043278">
<property type="term" value="P:response to morphine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.215.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.530.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR014716">
<property type="entry name" value="Fibrinogen_a/b/g_C_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR014715">
<property type="entry name" value="Fibrinogen_a/b/g_C_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR002181">
<property type="entry name" value="Fibrinogen_a/b/g_C_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR012290">
<property type="entry name" value="Fibrinogen_a/b/g_coil_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR021996">
<property type="entry name" value="Fibrinogen_aC"/>
</dbReference>
<dbReference type="InterPro" id="IPR020837">
<property type="entry name" value="Fibrinogen_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF08702">
<property type="entry name" value="Fib_alpha"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12160">
<property type="entry name" value="Fibrinogen_aC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00147">
<property type="entry name" value="Fibrinogen_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00186">
<property type="entry name" value="FBG"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56496">
<property type="entry name" value="SSF56496"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00514">
<property type="entry name" value="FIBRINOGEN_C_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51406">
<property type="entry name" value="FIBRINOGEN_C_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1064">Adaptive immunity</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0034">Amyloid</keyword>
<keyword id="KW-1008">Amyloidosis</keyword>
<keyword id="KW-0094">Blood coagulation</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0356">Hemostasis</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<feature type="signal peptide" evidence="31 41 42">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="peptide" description="Fibrinopeptide A" id="PRO_0000009021">
<location>
<begin position="20"/>
<end position="35"/>
</location>
</feature>
<feature type="chain" description="Fibrinogen alpha chain" id="PRO_0000009022">
<location>
<begin position="36"/>
<end position="866"/>
</location>
</feature>
<feature type="domain" description="Fibrinogen C-terminal" evidence="15">
<location>
<begin position="623"/>
<end position="864"/>
</location>
</feature>
<feature type="region of interest" description="Alpha-chain polymerization, binding distal domain of another fibrin gamma chain">
<location>
<begin position="36"/>
<end position="38"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="48">
<location>
<begin position="68"/>
<end position="631"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="4 40">
<location>
<position position="791"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="4 40">
<location>
<position position="793"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="4 40">
<location>
<position position="795"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="4 40">
<location>
<position position="797"/>
</location>
</feature>
<feature type="site" description="Cleavage; by thrombin; to release fibrinopeptide A">
<location>
<begin position="35"/>
<end position="36"/>
</location>
</feature>
<feature type="site" description="Cleavage; by plasmin; to break down fibrin clots">
<location>
<begin position="100"/>
<end position="101"/>
</location>
</feature>
<feature type="site" description="Cleavage; by hementin; to prevent blood coagulation">
<location>
<begin position="121"/>
<end position="122"/>
</location>
</feature>
<feature type="site" description="Cleavage; by plasmin; to break down fibrin clots">
<location>
<begin position="123"/>
<end position="124"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="22"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="11 30">
<location>
<position position="45"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="50"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="30">
<location>
<position position="56"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="281"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="291"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="294"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="30">
<location>
<position position="364"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 11">
<location>
<position position="412"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="451"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="501"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="505"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="30">
<location>
<position position="524"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="30">
<location>
<position position="560"/>
</location>
</feature>
<feature type="modified residue" description="4-hydroxyproline; by P4HA1" evidence="24">
<location>
<position position="565"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="10 11 30">
<location>
<position position="609"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...)" evidence="27">
<location>
<position position="320"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...)" evidence="27">
<location>
<position position="351"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...); in variant Caracas-2">
<location>
<position position="453"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="18 22 40">
<location>
<position position="686"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="23">
<location>
<position position="47"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (with C-95 in beta chain)" evidence="23">
<location>
<position position="55"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (with C-49 in gamma chain)" evidence="23">
<location>
<position position="64"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (with C-106 in beta chain)" evidence="23">
<location>
<position position="68"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (with C-165 in gamma chain)" evidence="23 32 37 39">
<location>
<position position="180"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (with C-223 in beta chain)" evidence="23 32 37 39">
<location>
<position position="184"/>
</location>
</feature>
<feature type="disulfide bond" evidence="13">
<location>
<begin position="461"/>
<end position="491"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 40">
<location>
<begin position="799"/>
<end position="812"/>
</location>
</feature>
<feature type="cross-link" description="Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-41 in alpha-2-antiplasmin)">
<location>
<position position="322"/>
</location>
</feature>
<feature type="cross-link" description="Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?)">
<location>
<position position="347"/>
</location>
</feature>
<feature type="cross-link" description="Isoglutamyl lysine isopeptide (Gln-Lys) (interchain with K-?)">
<location>
<position position="385"/>
</location>
</feature>
<feature type="cross-link" description="Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?)" evidence="14">
<location>
<position position="527"/>
</location>
</feature>
<feature type="cross-link" description="Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?)" evidence="14">
<location>
<position position="558"/>
</location>
</feature>
<feature type="cross-link" description="Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?)" evidence="14">
<location>
<position position="575"/>
</location>
</feature>
<feature type="cross-link" description="Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?)" evidence="14">
<location>
<position position="581"/>
</location>
</feature>
<feature type="cross-link" description="Isoglutamyl lysine isopeptide (Lys-Gln) (interchain with Q-?)" evidence="14">
<location>
<position position="599"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_001531" evidence="44 45 46">
<original>DCDDVLQTHPSGTQ</original>
<variation>GIHTSPLGKPSLSP</variation>
<location>
<begin position="631"/>
<end position="644"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_001532" evidence="44 45 46">
<location>
<begin position="645"/>
<end position="866"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2070025." id="VAR_011609" evidence="43">
<original>I</original>
<variation>V</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="sequence variant" description="In Lille-1." id="VAR_002390">
<original>D</original>
<variation>N</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In Rouen-1." id="VAR_002391">
<original>G</original>
<variation>V</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In DYSFIBRIN; fibrinogen Metz 1/Hershey III." id="VAR_002392" evidence="21">
<original>R</original>
<variation>C</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_002393" evidence="34">
<original>R</original>
<variation>H</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In Kyoto-2." id="VAR_002394" evidence="25">
<original>P</original>
<variation>L</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In Aarhus-1." id="VAR_002397">
<original>R</original>
<variation>G</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="sequence variant" description="In Munich-1; requires 2 nucleotide substitutions." id="VAR_002395">
<original>R</original>
<variation>N</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="sequence variant" description="In Detroit-1." id="VAR_002396">
<original>R</original>
<variation>S</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="sequence variant" description="In Canterbury." id="VAR_010730" evidence="36">
<original>V</original>
<variation>D</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In CAFBN; hypofibrinogenemia; heterozygous; decreased fibrinogen complex assembly; no effect on fibrinogen complex secretion." id="VAR_072721" evidence="29">
<original>C</original>
<variation>R</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_002398">
<original>S</original>
<variation>T</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In CAFBN; hypofibrinogenemia; heterozygous; no effect on fibrinogen complex assembly; no effect on fibrinogen complex secretion." id="VAR_072722" evidence="29">
<original>R</original>
<variation>P</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In Lima." id="VAR_002399" evidence="19">
<original>R</original>
<variation>S</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In CAFBN; hypofibrinogenemia; heterozygous; impaired fibrinogen complex assembly." id="VAR_072723" evidence="29">
<original>C</original>
<variation>W</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6050." id="VAR_011610" evidence="16 17 43">
<original>T</original>
<variation>A</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6052." id="VAR_014168" evidence="16">
<original>K</original>
<variation>E</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence variant" description="In Caracas-2." id="VAR_002400" evidence="20">
<original>S</original>
<variation>N</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2070031." id="VAR_011611" evidence="43">
<original>T</original>
<variation>A</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In AMYL8." id="VAR_010731">
<original>E</original>
<variation>V</variation>
<location>
<position position="545"/>
</location>
</feature>
<feature type="sequence variant" description="In DYSFIBRIN; fibrinogen Dusart/Paris-5." id="VAR_002401" evidence="35">
<original>R</original>
<variation>C</variation>
<location>
<position position="573"/>
</location>
</feature>
<feature type="sequence variant" description="In AMYL8." id="VAR_010732" evidence="33">
<original>R</original>
<variation>L</variation>
<location>
<position position="573"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF83248." ref="4" evidence="47">
<original>I</original>
<variation>V</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AA sequence." ref="10" evidence="47">
<original>SR</original>
<variation>RS</variation>
<location>
<begin position="215"/>
<end position="216"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AA sequence." ref="10" evidence="47">
<original>S</original>
<variation>G</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 10; AA sequence." ref="10" evidence="47">
<original>S</original>
<variation>G</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; AA sequence." ref="11" evidence="47">
<original>GT</original>
<variation>SG</variation>
<location>
<begin position="317"/>
<end position="318"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="27"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="57"/>
<end position="60"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="67"/>
<end position="92"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="94"/>
<end position="111"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="116"/>
<end position="129"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="142"/>
<end position="178"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="179"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="184"/>
<end position="186"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="195"/>
<end position="209"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="226"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="337"/>
<end position="343"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="582"/>
<end position="587"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="673"/>
<end position="681"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="689"/>
<end position="694"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="711"/>
<end position="718"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="723"/>
<end position="729"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="735"/>
<end position="744"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="747"/>
<end position="751"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="753"/>
<end position="762"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="765"/>
<end position="768"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="771"/>
<end position="773"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="775"/>
<end position="778"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="793"/>
<end position="797"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="799"/>
<end position="803"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="810"/>
<end position="812"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="814"/>
<end position="816"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="823"/>
<end position="826"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="829"/>
<end position="831"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="840"/>
<end position="843"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="844"/>
<end position="847"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="854"/>
<end position="861"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1BBR"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FZA"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FZC"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FZD"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1RE3"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GHG"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4F27"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CFA"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16807684"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18088087"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="E9PV24"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P02672"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255"/>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00739"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391209"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1634621"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1675636"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16846481"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19296670"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19696023"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2070049"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2143188"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23050552"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23151259"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25427968"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26091039"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="518846"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="741445"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8097946"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8461606"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8473507"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8675656"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9333233"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="936108"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9628725"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9689040"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source ref="10"/>
</evidence>
<evidence key="42" type="ECO:0000269">
<source ref="14"/>
</evidence>
<evidence key="43" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="6575389"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000305"/>
<evidence key="48" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19296670"/>
</source>
</evidence>
<sequence length="866" mass="94973" checksum="EA73A81204D8AEC4" modified="1996-10-01" version="2" precursor="true">
MFSMRIVCLVLSVVGTAWTADSGEGDFLAEGGGVRGPRVVERHQSACKDSDWPFCSDEDW
NYKCPSGCRMKGLIDEVNQDFTNRINKLKNSLFEYQKNNKDSHSLTTNIMEILRGDFSSA
NNRDNTYNRVSEDLRSRIEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSC
RGSCSRALAREVDLKDYEDQQKQLEQVIAKDLLPSRDRQHLPLIKMKPVPDLVPGNFKSQ
LQKVPPEWKALTDMPQMRMELERPGGNEITRGGSTSYGTGSETESPRNPSSAGSWNSGSS
GPGSTGNRNPGSSGTGGTATWKPGSSGPGSTGSWNSGSSGTGSTGNQNPGSPRPGSTGTW
NPGSSERGSAGHWTSESSVSGSTGQWHSESGSFRPDSPGSGNARPNNPDWGTFEEVSGNV
SPGTRREYHTEKLVTSKGDKELRTGKEKVTSGSTTTTRRSCSKTVTKTVIGPDGHKEVTK
EVVTSEDGSDCPEAMDLGTLSGIGTLDGFRHRHPDEAAFFDTASTGKTFPGFFSPMLGEF
VSETESRGSESGIFTNTKESSSHHPGIAEFPSRGKSSSYSKQFTSSTSYNRGDSTFESKS
YKMADEAGSEADHEGTHSTKRGHAKSRPVRDCDDVLQTHPSGTQSGIFNIKLPGSSKIFS
VYCDQETSLGGWLLIQQRMDGSLNFNRTWQDYKRGFGSLNDEGEGEFWLGNDYLHLLTQR
GSVLRVELEDWAGNEAYAEYHFRVGSEAEGYALQVSSYEGTAGDALIEGSVEEGAEYTSH
NNMQFSTFDRDADQWEENCAEVYGGGWWYNNCQAANLNGIYYPGGSYDPRNNSPYEIENG
VVWVSFRGADYSLRAVRMKIRPLVTQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>